Lumexa Imaging Holdings, Inc. (LMRI)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$13.10+16.76%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · LMRI
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
No current thesis-health read is available for this company.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 35.7% |
| Our one-year growth estimate | diamond | 95.9% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 60.2 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name has been missing across recent quarters and is on a run of consecutive earnings misses. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 29 industry peers
LMRI — credit agreement
Dated 2026-06-30
Entry into a Material Definitive Agreement. On June 30, 2026, Lumexa Imaging, Inc. and Lumexa Imaging Outpatient, Inc. (collectively, the “ Borrowers ”), each an indirect wholly-owned subsidiary of Lumexa Imaging Holdings, Inc. (the “ Company ”), the other Loan Parties party thereto, the Lenders party thereto and Barclays Bank PLC, as administrative agent, entered into an amendment to their existing Credit Agreement (as so amended, the “ Amended Credit Agreement ”). Capitalized terms used her…
Why it matters: The next report is due November 10. Holding both ranges would support the current 2026 plan; a cut would weaken it.
Watch forOn November 10, Lumexa keeps 2026 revenue guidance at $1.045B–$1.097B and Adjusted EBITDA at $235M–$241M.
Also watch forOn November 10, Lumexa cuts either 2026 guidance range.
Why it matters: Lumexa narrowed its range but kept the midpoint at $238M. Results below the range would point to weaker earnings than guided.
Worry if2026 Adjusted EBITDA is below $235M, or management cuts the $235M–$241M range.
Less concerning if2026 Adjusted EBITDA is at least $235M and no more than $241M, with the range intact.
Why it matters: Management kept this 2026 target in both recent reports. Results inside the range would back its growth plan.
Supportive if2026 revenue is reported at $1.045B or more and no higher than $1.097B.
Worry if2026 revenue falls below $1.045B, or management cuts the range before year-end.
Why it matters: New centers and partnerships expand Lumexa's reach. The 8–10 de novo goal tests whether this expansion plan is on pace.
Supportive ifBy the end of 2026, Lumexa reports opening 8–10 new centers.
Worry ifLumexa reports fewer than 8 de novo center openings for 2026, or says the goal is delayed.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$138 on $10,000 · ±1.4% | How much price usually moves either way. |
| Bad day | $602 loss on $10,000 · 6.0% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,346 loss on $10,000 · 63.5% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.